| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(01)06524-2 |
| P698 | PubMed publication ID | 11705483 |
| P2093 | author name string | Collaborative Group on Hormonal Factors in Breast Cancer | |
| P2860 | cites work | The Million Women Study: design and characteristics of the study population. The Million Women Study Collaborative Group | Q24791125 |
| Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer | Q28142158 | ||
| Lactation and a reduced risk of premenopausal breast cancer | Q28257285 | ||
| Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies | Q28280957 | ||
| Risk factors for breast cancer with applications to selection for the prevalence screen | Q33686343 | ||
| Oral contraceptive use and breast cancer in young women. A joint national case-control study in Sweden and Norway | Q34559043 | ||
| Oral contraceptives and breast cancer in northern Italy. Final report from a case-control study | Q35976613 | ||
| The pattern of risk factors for breast cancer in a southern France population. Interest for a stratified analysis by age at diagnosis | Q35993321 | ||
| Early oral contraceptive use and breast cancer: results of another case-control study | Q36028555 | ||
| Oral contraceptives and breast cancer: final report of an epidemiological study | Q36047603 | ||
| Oral contraceptives and breast cancer: results from an expanded case-control study | Q36467692 | ||
| Breast-cancer risk and oral contraceptive use in Slovenian women aged 25 to 54. | Q38508633 | ||
| Age at last full-term pregnancy and risk of breast cancer | Q39115962 | ||
| A breast cancer case-control study in Girona, Spain. Endocrine, familial and lifestyle factors | Q39437962 | ||
| Design and analysis issues in a population-based, case-control-family study of the genetic epidemiology of breast cancer and the Co-operative Family Registry for Breast Cancer Studies (CFRBCS). | Q40760869 | ||
| Breast cancer among young U.S. women in relation to oral contraceptive use. | Q41036451 | ||
| Risk factors for breast cancer by age and menopausal status: a case-control study in Singapore | Q41125791 | ||
| Effect of family history, body-fat distribution, and reproductive factors on the risk of postmenopausal breast cancer | Q42610230 | ||
| Oral contraceptives and risk of breast cancer | Q43522009 | ||
| Breast cancer risk and oral contraceptive use: results from a large case-control study | Q44448272 | ||
| Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group | Q44693258 | ||
| The association of replacement estrogens with breast cancer | Q44725506 | ||
| Prospective study of oral contraceptive use and risk of breast cancer in women. | Q52520686 | ||
| Oral contraceptives and breast cancer: a French case-control study. | Q52864690 | ||
| Oral contraceptives and breast cancer: a cooperative Italian study. | Q52880273 | ||
| Comparative case-referent study of risk factors among hormone-related female cancers in Japan. | Q55346935 | ||
| Breast cancer in Australian women under the age of 40 | Q57265906 | ||
| Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy | Q57549470 | ||
| Alcohol and breast cancer in the Swiss Canton of Vaud | Q57561363 | ||
| Menopausal estrogen and estrogen-progestin replacement therapy and risk of breast cancer (United States) | Q61831804 | ||
| Exogenous hormone use and the risk of postmenopausal breast cancer: results from the Netherlands Cohort Study | Q61988449 | ||
| A Case-Control Study of the Risk of Breast Cancer in Relation to Oral Contraceptive Use | Q67471862 | ||
| Oral contraceptive agents and breast cancer: a population-based case-control study | Q67959487 | ||
| Risk factors for female breast cancer. A hospital-based case-control study in Madras, India | Q67973991 | ||
| Noncontraceptive hormone use and risk of breast cancer | Q68045042 | ||
| Breast cancer and breastfeeding: results from an Australian case-control study | Q69661768 | ||
| Role of fat, animal protein, and dietary fiber in breast cancer etiology: a case-control study | Q70146606 | ||
| Oral contraceptive use and risk of breast cancer in middle-aged women | Q71181613 | ||
| Oral contraceptives, menopausal estrogens, and the risk of breast cancer: a case-control study in Greece | Q72036057 | ||
| Oral contraceptives and breast cancer risk among younger women | Q72335615 | ||
| Family history, age, and risk of fatal breast cancer | Q72601922 | ||
| Oral contraceptives and risk of breast cancer in women aged 20-54 years. Netherlands Oral Contraceptives and Breast Cancer Study Group | Q72692127 | ||
| P433 | issue | 9291 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | epidemiology | Q133805 |
| collaboration | Q1145523 | ||
| maternal health | Q6786626 | ||
| breast cancer | Q128581 | ||
| data collaboration | Q96060107 | ||
| P304 | page(s) | 1389-1399 | |
| P577 | publication date | 2001-10-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease | |
| P478 | volume | 358 |
| Q37169873 | 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium |
| Q52019530 | A Prospective Comparison Study of Different Methods of Gathering Self-Reported Family History Information for Breast Cancer Risk Assessment. |
| Q60029894 | A Qualitative Evaluation of the Psychosocial Impact of Family History Screening in Australian Primary Care |
| Q58741224 | A case-control study of breast cancer risk factors in 7,663 women in Malaysia |
| Q47156852 | A case-control study on risk factors of breast cancer in Han Chinese women |
| Q57250674 | A common coding variant in CASP8 is associated with breast cancer risk |
| Q37277137 | A constant risk for familial breast cancer? A population-based family study |
| Q52633981 | A dietary pattern based on estrogen metabolism is associated with breast cancer risk in a prospective cohort of postmenopausal women. |
| Q33354606 | A family history of breast cancer will not predict female early onset breast cancer in a population-based setting |
| Q40906978 | A family-based, genome-wide association study of young-onset breast cancer: inherited variants and maternally mediated effects. |
| Q36644199 | A follow-up study of breast and other cancers in families of an unselected series of breast cancer patients |
| Q41725974 | A genetic variant at 12p11 significantly modifies breast cancer risk in a genetically homogenous island population |
| Q37272982 | A genome wide linkage search for breast cancer susceptibility genes |
| Q29417036 | A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age. |
| Q37312261 | A loss-of-function polymorphism in the propeptide domain of the LOX gene and breast cancer |
| Q47898378 | A novel loss-of-function heterozygous BRCA2 c.8946_8947delAG mutation found in a Chinese woman with family history of breast cancer |
| Q37258834 | A population based case control study on breast cancer and the associated risk factors in a rural setting in kerala, southern India |
| Q37710564 | A risk of breast cancer in women - carriers of constitutional CHEK2 gene mutations, originating from the North - Central Poland |
| Q57025547 | A treelet transform analysis to relate nutrient patterns to the risk of hormonal receptor-defined breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) |
| Q30318240 | AGO Recommendations for Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer. Update 2011. |
| Q35169608 | AKT1/BRCA1 in the control of homologous recombination and genetic stability: the missing link between hereditary and sporadic breast cancers |
| Q37105163 | Accuracy of Self-Reported Screening Mammography Use: Examining Recall among Female Relatives from the Ontario Site of the Breast Cancer Family Registry |
| Q35231571 | Adherence to breast and ovarian cancer screening recommendations for female relatives from the Ontario site of the Breast Cancer Family Registry |
| Q58605582 | Adult physical activity and breast cancer risk in women with a family history of breast cancer |
| Q33515727 | Age of onset in familial breast cancer as background data for medical surveillance |
| Q37321949 | Age of onset in familial cancer |
| Q54550455 | Allelic imbalance in BRCA1 and BRCA2 gene expression is associated with an increased breast cancer risk. |
| Q33667724 | An investigation of breast cancer risk factors in Cyprus: a case control study |
| Q86284986 | Analysis of PALB2 mutations in 155 Japanese patients with breast and/or ovarian cancer |
| Q88336455 | Analysis of factors predicting surgical intervention and associated costs in pediatric breast masses: a single center study |
| Q33199899 | Analysis of menstrual, reproductive, and life-style factors for breast cancer risk in Turkish women: a case-control study. |
| Q36787357 | Are the so-called low penetrance breast cancer genes, ATM, BRIP1, PALB2 and CHEK2, high risk for women with strong family histories? |
| Q34765941 | Assessing SNP-SNP interactions among DNA repair, modification and metabolism related pathway genes in breast cancer susceptibility |
| Q39002424 | Assessing absolute changes in breast cancer risk due to modifiable risk factors |
| Q44012419 | Assessing interactions between the associations of fibroblast growth factor receptor 2 common genetic variants and hormone receptor status with breast cancer risk |
| Q37039769 | Assessing risk for breast cancer |
| Q37739036 | Assessing women at high risk of breast cancer: a review of risk assessment models |
| Q34973918 | Association between 1p11-rs11249433 polymorphism and breast cancer susceptibility: evidence from 15 case-control studies |
| Q36823374 | Association between breast cancer, breast density, and body adiposity evaluated by MRI |
| Q51275648 | Association between cancer screening behavior and family history among Japanese women. |
| Q33279162 | Association between common variation in 120 candidate genes and breast cancer risk |
| Q30974379 | Association of Epstein Barr virus infection (EBV) with breast cancer in rural Indian women |
| Q36461696 | Association of polymorphisms with a family history of cancer and the presence of germline mutations in the BRCA1/BRCA2 genes |
| Q37385078 | Association of selected medical conditions with breast cancer risk in Korea |
| Q51009411 | Association of the BRCA1 promoter polymorphism rs11655505 with the risk of familial breast and/or ovarian cancer. |
| Q57568586 | Attributable risks for familial breast cancer by proband status and morphology: a nationwide epidemiologic study from Sweden |
| Q90375515 | BRCA testing in unaffected young women in the United States, 2006-2017 |
| Q64284450 | BRCA1 and Breast Cancer: a Review of the Underlying Mechanisms Resulting in the Tissue-Specific Tumorigenesis in Mutation Carriers |
| Q57744383 | BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanoma |
| Q57466036 | BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts |
| Q40042602 | Biology and etiology of young-onset breast cancers among premenopausal African American women: results from the AMBER Consortium |
| Q50046604 | Breast Cancer Family History and Allele-Specific DNA Methylation in the Legacy Girls Study. |
| Q57420847 | Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology Study |
| Q33206389 | Breast Cancer in Canadian Women |
| Q64264117 | Breast Cancer in Very Young Patients in a Spanish Cohort: Age as an Independent Bad Prognostic Indicator |
| Q90241672 | Breast cancer |
| Q56994859 | Breast cancer |
| Q30705774 | Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease |
| Q33948726 | Breast cancer before age 40 years |
| Q57112840 | Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis |
| Q33418922 | Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort |
| Q57133852 | Breast cancer in young women |
| Q37386043 | Breast cancer knowledge and early detection among Hispanic women with a family history of breast cancer along the U.S.-Mexico border |
| Q33709272 | Breast cancer relatives' physical activity intervention needs and preferences: qualitative results |
| Q26851902 | Breast cancer risk accumulation starts early: prevention must also |
| Q43506189 | Breast cancer risk among women with long-standing lactation and reproductive parameters at low risk level: a case-control study in Northern Tanzania |
| Q57266500 | Breast cancer risk assessment in 8,824 women attending a family history evaluation and screening programme |
| Q42286112 | Breast cancer risk factors in relation to estrogen receptor, progesterone receptor, insulin-like growth factor-1 receptor, and Ki67 expression in normal breast tissue |
| Q35847689 | Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors |
| Q49249232 | Breast cancer risk in a screening cohort of Asian and white British/Irish women from Manchester UK. |
| Q39636096 | Breast cancer risk in healthy and symptomatic women: results of a multivariate analysis. A case-control study |
| Q35592002 | Breast cancer risk in older women: results from the NIH-AARP Diet and Health Study |
| Q33623757 | Breast cancer risk perception and lifestyle behaviors among White and Black women with a family history of the disease |
| Q37081117 | Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation |
| Q28215038 | Breast cancer susceptibility-A new look at an old model |
| Q37598890 | Breast cancer: beyond the cutting edge |
| Q35204980 | Breast cancer: occurrence, risk factors and hormone metabolism |
| Q34148873 | Breast-cancer risk in families with mutations in PALB2 |
| Q33910280 | CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies |
| Q37446428 | Calibrated predictions for multivariate competing risks models |
| Q83826662 | Cancer genetics service interest in women with a limited family history of breast cancer |
| Q34992880 | Cancer risk assessment for the primary care physician |
| Q53388584 | Cancer risks in twins: results from the Swedish family-cancer database. |
| Q24813705 | Changes in body weight and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers |
| Q37281706 | Chromosome 9 arm-specific telomere length and breast cancer risk |
| Q33565679 | Cis-eQTL-based trans-ethnic meta-analysis reveals novel genes associated with breast cancer risk. |
| Q89746441 | Clinical applications of polygenic breast cancer risk: a critical review and perspectives of an emerging field |
| Q35039478 | Clinical considerations in the management of individuals at risk for hereditary breast and ovarian cancer. |
| Q36465283 | Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases |
| Q37026848 | Clinical features and pattern of presentation of breast diseases in surgical outpatient clinic of a suburban tertiary hospital in South-west Nigeria |
| Q46301419 | Clinicopathologic and prognostic features of breast cancer in young women: a series from North of Morocco. |
| Q37219731 | Cohort Profile: The Breast Cancer Prospective Family Study Cohort (ProF-SC) |
| Q36613270 | Collecting Family Health History using an Online Social Network: a Nationwide Survey among Potential Users |
| Q48159694 | Combined annotation-dependent depletion score for BRCA1/2 variants in patients with breast and/or ovarian cancer |
| Q24797594 | Common ERBB2 polymorphisms and risk of breast cancer in a white British population: a case-control study |
| Q36856357 | Common genetic determinants of breast-cancer risk in East Asian women: a collaborative study of 23 637 breast cancer cases and 25 579 controls |
| Q24658131 | Common genetic variation in candidate genes and susceptibility to subtypes of breast cancer |
| Q21260438 | Common variation in EMSY and risk of breast and ovarian cancer: a case-control study using HapMap tagging SNPs |
| Q37235167 | Comparison of genetic variation of breast cancer susceptibility genes in Chinese and German populations. |
| Q47355342 | Comparison of women's breast cancer risk factors in Geneva, Switzerland and Shanghai, China |
| Q47990475 | Complex breast masses: assessment of malignant potential based on cyst diameter. |
| Q47145727 | Computational Investigation of Homologous Recombination DNA Repair Deficiency in Sporadic Breast Cancer |
| Q34821135 | Consensus recommendations for advancing breast cancer: risk identification and screening in ethnically diverse younger women |
| Q34678705 | Contralateral prophylactic mastectomy in the American College of Radiology Imaging Network 6667 trial: effect of breast MR imaging assessments and patient characteristics |
| Q45984889 | Contrasting epistatic interactions between rat quantitative trait loci controlling mammary cancer development. |
| Q37953513 | Correlation of age at oral contraceptive pill start with age at breast cancer diagnosis. |
| Q36625999 | Correlations between family history and cancer characteristics in 2256 breast cancer patients |
| Q31161376 | Cross-sectional analysis of BioBank Japan clinical data: A large cohort of 200,000 patients with 47 common diseases |
| Q34770599 | DNA methylation and breast carcinogenesis. |
| Q50722910 | Determinants of genetic counseling uptake and its impact on breast cancer outcome: a population-based study. |
| Q37102032 | Developing Family Healthware, a family history screening tool to prevent common chronic diseases |
| Q92111392 | Developing a community-based breast cancer risk prediction tool for resource-poor settings |
| Q35611495 | Development and Evaluation of the Curriculum for BOLD (Bronx Oncology Living Daily) Healthy Living: a Diabetes Prevention and Control Program for Underserved Cancer Survivors |
| Q33599684 | Development and validation of a family history screening questionnaire in Australian primary care. |
| Q35204017 | Development and validation of risk prediction algorithms to estimate future risk of common cancers in men and women: prospective cohort study |
| Q98226263 | Diet and Transgenerational Epigenetic Inheritance of Breast Cancer: The Role of the Paternal Germline |
| Q26751985 | Diet and risk of breast cancer |
| Q92989791 | Dietary index scores and invasive breast cancer risk among women with a family history of breast cancer |
| Q36725148 | Dietary patterns and breast cancer risk among women in northern Tanzania: a case-control study |
| Q37655850 | Differences in DNA methylation by extent of breast cancer family history in unaffected women |
| Q37021751 | Differences in estrogen receptor subtype according to family history of breast cancer among Hispanic, but not non-Hispanic White women |
| Q58701459 | Distinct epidemiological profiles associated with inflammatory breast cancer (IBC): A comprehensive analysis of the IBC registry at The University of Texas MD Anderson Cancer Center |
| Q33985107 | Do alterations in mitochondrial DNA play a role in breast carcinogenesis? |
| Q44447660 | Does birth history account for educational differences in breast cancer mortality? A comparison of premenopausal and postmenopausal women in Belgium |
| Q35049656 | Does perceived risk predict breast cancer screening use? Findings from a prospective cohort study of female relatives from the Ontario site of the breast cancer family registry |
| Q59159730 | Does the occurrence of certain rare cancers indicate an inherited cancer susceptibility? |
| Q34556879 | Does thyroid dysfunction increase the risk of breast cancer? A systematic review and meta-analysis |
| Q83172031 | Early breast cancer |
| Q35036644 | Educational differences in postmenopausal breast cancer--quantifying indirect effects through health behaviors, body mass index and reproductive patterns |
| Q57918694 | Effect of familial history and smoking on common cancer risks in Japan |
| Q57108215 | Elucidating the Underlying Functional Mechanisms of Breast Cancer Susceptibility Through Post-GWAS Analyses |
| Q46932137 | Emerging Trends in Family History of Breast Cancer and Associated Risk |
| Q38650160 | Enhanced Identification of Potential Pleiotropic Genetic Variants for Bone Mineral Density and Breast Cancer |
| Q57105691 | Epidemiology of Moderate Alcohol Consumption and Breast Cancer: Association or Causation? |
| Q52006900 | Epidemiology of breast cancer--selected highlights. |
| Q30319186 | Established and Suspected Risk Factors in Breast Cancer Aetiology |
| Q36983389 | Establishing a program for individuals at high risk for breast cancer |
| Q36609446 | Estimates of heritable and environmental components of familial breast cancer using family history information |
| Q36609775 | Estimating the referral rate for cancer genetic assessment from a systematic review of the evidence |
| Q34336219 | Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study |
| Q37459575 | Ethnic differences in breast cancer incidence in England are due to differences in known risk factors for the disease: prospective study |
| Q37307773 | Evaluating breast cancer risk projections for Hispanic women |
| Q37004792 | Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer |
| Q36643111 | Evaluation of unclassified variants in the breast cancer susceptibility genes BRCA1 and BRCA2 using five methods: results from a population-based study of young breast cancer patients |
| Q34621004 | Exposure to low-dose radiation and the risk of breast cancer among women with a familial or genetic predisposition: a meta-analysis |
| Q64240710 | Expression and prognostic significance of Fanconi anemia group D2 protein and breast cancer type 1 susceptibility protein in familial and sporadic breast cancer |
| Q35999309 | FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity and is a familial breast cancer risk factor |
| Q36237033 | Factors affecting frequency of communication about family health history with family members and doctors in a medically underserved population |
| Q57306010 | Familial Risks, Early-Onset Breast Cancer, and BRCA1 and BRCA2 Germline Mutations |
| Q92748563 | Familial aggregation of early-onset cancers |
| Q44260470 | Familial breast cancer: scope for more susceptibility genes? |
| Q74455738 | Familial breast carcinoma risks by morphology: a nationwide epidemiologic study from Sweden |
| Q35687887 | Familial clustering of breast and prostate cancer and risk of postmenopausal breast cancer in the Women's Health Initiative Study. |
| Q81826701 | Familial nasopharyngeal carcinoma in Hong Kong: epidemiology and implication in screening |
| Q33892928 | Familial relative risks for breast cancer by pathological subtype: a population-based cohort study |
| Q90185304 | Familial risk of breast cancer by dynamic, accumulative, and static definitions of family history |
| Q35165420 | Familial risks and estrogen receptor-positive breast cancer in Hong Kong Chinese women. |
| Q24802759 | Familial risks of breast cancer |
| Q50020885 | Family History and Risk of Second Primary Breast Cancer after In Situ Breast Carcinoma. |
| Q38769347 | Family History of Breast Cancer, Breast Density, and Breast Cancer Risk in a U.S. Breast Cancer Screening Population |
| Q57266614 | Family History of Cancer and Cancer Risks in Women with BRCA1 or BRCA2 Mutations |
| Q36619735 | Family History of Cancer in Relation to Breast Cancer Subtypes in African American Women |
| Q34078815 | Family history and age at onset of breast cancer in Hispanic and non-Hispanic white women |
| Q40923313 | Family history and outcome of young patients with breast cancer in the UK (POSH study). |
| Q38746332 | Family history and risk of breast cancer: an analysis accounting for family structure |
| Q34255796 | Family history and risk of breast cancer: nurses' health study |
| Q37363424 | Family history and risk of ductal carcinoma in situ and triple negative breast cancer in a Han Chinese population: a case-control study |
| Q57199773 | Family history and risk of pregnancy-associated breast cancer (PABC) |
| Q45230424 | Family history and the risk of cancer: genetic factors influencing multiple cancer sites |
| Q30620701 | Family history of breast and ovarian cancer and triple negative subtype in hispanic/latina women |
| Q37308563 | Family history of breast cancer and all-cause mortality after breast cancer diagnosis in the Breast Cancer Family Registry |
| Q34227600 | Family history of breast cancer and cost of life assurance: a test case comparison of current UK industry practice |
| Q36895125 | Family history of breast cancer and its association with disease severity and mortality |
| Q34687179 | Family history of breast cancer in first-degree relatives and triple-negative breast cancer risk |
| Q47160653 | Family history of breast cancer: Authors' reply |
| Q43002090 | Family history of breast cancer: referral guidelines changed after acceptance of 10 minute consultation |
| Q37479133 | Family history of cancer and risk of breast cancer in the Black Women's Health Study |
| Q31034983 | Family history of gastric cancer: a correlation between epidemiologic findings and clinical data. |
| Q31160201 | Family history of malignancies and risk of breast cancer: prospective data from the Shanghai women's health study |
| Q34556066 | Fibroblast growth factor receptors in breast cancer |
| Q39844032 | Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer |
| Q38024316 | Folate and breast cancer: what about high-risk women? |
| Q37658464 | Frailty Models for Familial Risk with Application to Breast Cancer |
| Q39730889 | Functional Analysis of Missense Variants in the Putative Breast Cancer Susceptibility Gene XRCC2. |
| Q46015936 | Gail model risk factors: impact of adding an extended family history for breast cancer. |
| Q90824840 | Gene-based and pathway-based testing for rare-variant association in affected sib pairs |
| Q33935171 | Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study |
| Q48169351 | Genetic assessment wait time indicators in the High Risk Ontario Breast Screening Program |
| Q37834134 | Genetic modifiers of cancer risk for BRCA1 and BRCA2 mutation carriers |
| Q34367710 | Genetic predisposition, parity, age at first childbirth and risk for breast cancer |
| Q41130542 | Genetic susceptibility to breast cancer |
| Q35263848 | Genetic testing for familial/hereditary breast cancer-comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany |
| Q34497690 | Genetic variants in epigenetic genes and breast cancer risk. |
| Q84586658 | Genetic variants of EGFR (142285G>A) and ESR1 (2014G>A) gene polymorphisms and risk of breast cancer |
| Q35179897 | Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study |
| Q35552631 | Genetics and the Management of Women at High Risk for Breast Cancer |
| Q24645441 | Genome-wide association study identifies novel breast cancer susceptibility loci |
| Q34295620 | Genome-wide association study of circulating estradiol, testosterone, and sex hormone-binding globulin in postmenopausal women |
| Q51691340 | Genome-wide linkage scan in Dutch hereditary non-BRCA1/2 breast cancer families identifies 9q21-22 as a putative breast cancer susceptibility locus. |
| Q80629440 | Germline mutations in the breast cancer susceptibility gene PTEN are rare in high-risk non-BRCA1/2 French Canadian breast cancer families |
| Q40892042 | HBOC multi-gene panel testing: comparison of two sequencing centers |
| Q46203770 | HRT and breast cancer: recent findings in the context of the evidence to date |
| Q92916937 | Health and Racial Disparity in Breast Cancer |
| Q81280228 | Health behaviors and psychological distress in women initiating BRCA1/2 genetic testing: comparison with control population |
| Q44660334 | Healthy lifestyle and risk of breast cancer among postmenopausal women in the European Prospective Investigation into Cancer and Nutrition cohort study |
| Q36311502 | Hereditary breast and ovarian cancer: review and future perspectives |
| Q41107963 | Hereditary breast cancer associated with Cowden syndrome-related PTEN mutation with Lhermitte-Duclos disease. |
| Q48469722 | High incidence of familial breast cancer segregates with constitutional t(11;22)(q23;q11). |
| Q36606072 | High-fat or ethinyl-oestradiol intake during pregnancy increases mammary cancer risk in several generations of offspring |
| Q34120493 | Hormonal contraception and risk of cancer. |
| Q34953339 | Hormonal risk factors for breast cancer: identification, chemoprevention, and other intervention strategies |
| Q35017932 | Hormone-related risk factors and postmenopausal breast cancer among nulliparous versus parous women: An aggregated study |
| Q28077578 | Identification and management of women with a family history of breast cancer: Practical guide for clinicians |
| Q28077316 | Identification et prise en charge des femmes ayant des antécédents familiaux de cancer du sein: Guide pratique à l’intention des médecins |
| Q34743854 | Identification of a breast cancer susceptibility locus at 4q31.22 using a genome-wide association study paradigm |
| Q57712556 | Imaging Phenotypes in Women at High Risk for Breast Cancer on Mammography, Ultrasound, and Magnetic Resonance Imaging Using the Fifth Edition of the Breast Imaging Reporting and Data System |
| Q47212867 | Impact of breast cancer family history on tumor detection and tumor size in women newly-diagnosed with invasive breast cancer |
| Q51196865 | Impact of familial risk and mammography screening on prognostic indicators of breast disease among women from the Ontario site of the Breast Cancer Family Registry. |
| Q36613647 | Impact of familial risk factors on management and survival of early-onset breast cancer: a population-based study |
| Q31157610 | Impact of self-reported data on the acquisition of multi-generational family history and lifestyle factors among women seen in a high-risk breast screening program: a focus on modifiable risk factors and genetic referral |
| Q37670809 | Implications of single nucleotide polymorphisms in CD44 exon 2 for risk of breast cancer |
| Q36031290 | Importance of hereditary and selected environmental risk factors in the etiology of inflammatory breast cancer: a case-comparison study |
| Q35015572 | In search of breast cancer culprits: suspecting the suspected and the unsuspected |
| Q37378034 | Incorporating truncating variants in PALB2, CHEK2, and ATM into the BOADICEA breast cancer risk model |
| Q34250215 | Increased cancer risks for relatives of very early-onset breast cancer cases with and without BRCA1 and BRCA2 mutations |
| Q36243132 | Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium |
| Q35472998 | Individual having a parent with early-onset gastric cancer may need screening at younger age. |
| Q38610326 | Individuals with FANCM biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragility |
| Q35013740 | Influence of perceived breast cancer risk on screening behaviors of female relatives from the Ontario site of the Breast Cancer Family Registry |
| Q90279891 | Inquiry and computer program Onko-Online: 25 years of clinical registry for breast cancer at the University Medical Centre Maribor |
| Q24652651 | Interactions between genes involved in the antioxidant defence system and breast cancer risk |
| Q47097836 | Interactions of Family History of Breast Cancer with Radiotherapy in Relation to the Risk of Breast Cancer Recurrence. |
| Q36377455 | Internet-based physical activity intervention for women with a family history of breast cancer |
| Q37292981 | Interviews with primary care physicians regarding taking and interpreting the cancer family history |
| Q40247920 | Inverse birth cohort effects in ovarian cancer: Increasing risk in BRCA1/2 mutation carriers and decreasing risk in the general population. |
| Q36254990 | Is BRCA1/BRCA2-related breast carcinogenesis estrogen dependent? |
| Q41377330 | Is there an association between invasive lobular carcinoma of the breast and a family history of gastric cancer? |
| Q35552869 | Knowledge, attitude and practice of breast self-examination among female undergraduate students in the University of Buea. |
| Q35170028 | Lobular breast cancer: incidence and genetic and non-genetic risk factors |
| Q40509907 | Long-term effects of first degree family history of breast cancer in young women: Recurrences and bilateral breast cancer |
| Q33767027 | Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry |
| Q37024868 | Mammary cancer susceptibility: human genes and rodent models |
| Q36043843 | Mammographic breast density and breast cancer: evidence of a shared genetic basis |
| Q36336239 | Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort |
| Q24651187 | Mammographic screening before age 50 years in the UK: comparison of the radiation risks with the mortality benefits |
| Q26771184 | Managing breast cancer in younger women: challenges and solutions |
| Q90244199 | Mastectomy versus breast-conservation therapy: an examination of how individual, clinicopathologic, and physician factors influence decision-making |
| Q28086915 | Medical prevention of breast cancer |
| Q36602581 | Models of genetic susceptibility to breast cancer |
| Q37819443 | Molecular biological aspects on canine and human mammary tumors |
| Q33966572 | Mutation screening of the RNF8, UBC13 and MMS2 genes in Northern Finnish breast cancer families |
| Q39991531 | Mutational analysis of the breast cancer susceptibility gene BRIP1 /BACH1/FANCJ in high-risk non-BRCA1/BRCA2 breast cancer families |
| Q37096876 | No increase of breast cancer incidence in Japanese women who received hormone replacement therapy: overview of a case-control study of breast cancer risk in Japan |
| Q39006292 | Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study |
| Q33698278 | Novel drugs that target the estrogen-related receptor alpha: their therapeutic potential in breast cancer |
| Q35939849 | Obesity is a significant risk factor for breast cancer in Arab women |
| Q34213235 | Objective and subjective breast cancer risk: relationships with natural killer cell activity and psychological distress in healthy women |
| Q36800273 | On the avoidability of breast cancer in industrialized societies: older mean age at first birth as an indicator of excess breast cancer risk |
| Q30433319 | Oral contraceptives and postmenopausal hormones and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers and noncarriers: the WECARE Study |
| Q34216239 | Oral contraceptives and risk of ovarian and breast cancers in BRCA mutation carriers: a meta-analysis. |
| Q37649991 | Outcomes and chemotherapy-related toxicity in HIV-infected patients with breast cancer |
| Q61812261 | Overview of the genetic basis toward early detection of breast cancer |
| Q36289931 | P53 and Ki-67 as prognostic markers in triple-negative breast cancer patients |
| Q37732026 | PALB2 mutation in a woman with bilateral breast cancer: A case report |
| Q38720678 | PROLONGED BIRTH INTERVALS IN HAMEDAN, IRAN: VARIATIONS AND DETERMINANTS. |
| Q40844180 | Part I: Pituitary adenylate cyclase-activating polypeptide-38 induced migraine-like attacks in patients with and without familial aggregation of migraine |
| Q34023647 | Pathogenesis, prevention, diagnosis and treatment of breast cancer |
| Q34008159 | Pathway analysis of breast cancer genome-wide association study highlights three pathways and one canonical signaling cascade |
| Q57568108 | Patterns of changing cancer risks with time since diagnosis of a sibling |
| Q47418075 | Personal or first-degree family breast cancer history: which has higher impact on tumor detection and tumor size in breast cancer |
| Q37474410 | Plasma metabolomic profiles in breast cancer patients and healthy controls: by race and tumor receptor subtypes |
| Q37153515 | Plasma protein carbonyls and breast cancer risk in sisters discordant for breast cancer from the New York site of the Breast Cancer Family Registry |
| Q79162761 | Polygenic inheritance of breast cancer: Implications for design of association studies |
| Q37131918 | Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families |
| Q53676768 | Polymorphism in the manganese superoxide dismutase (MnSOD) gene and risk of breast cancer in young women. |
| Q52584349 | Polymorphisms in BER genes and risk of breast cancer: evidences from 69 studies with 33760 cases and 33252 controls. |
| Q36429795 | Polymorphisms of Phase I and Phase II Enzymes and Breast Cancer Risk |
| Q37216596 | Population-based estimates of the relation between breast cancer risk, tumor subtype, and family history |
| Q36287185 | Population-based family studies in genetic epidemiology |
| Q33809114 | Precision medicine in breast cancer: reality or utopia? |
| Q43820055 | Predicting breast cancer risk: implications of a "weak" family history |
| Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
| Q41130927 | Pregnancy history and risk of premenopausal breast cancer-a nested case-control study |
| Q44958136 | Prevention of breast cancer (part I): epidemiology, risk factors, and risk assessment tools |
| Q40474074 | Previous GWAS hits in relation to young-onset breast cancer. |
| Q39795642 | Proportion of women with self-reported opportunistic mammography before organized screening |
| Q96134332 | Prospective breast cancer risk factors prediction in Saudi women |
| Q35130901 | Prospective study of high-risk, BRCA1/2-mutation negative women: the 'negative study' |
| Q36484531 | Prospective surveillance of women with a family history of breast cancer: auditing the risk threshold |
| Q33916899 | Psychosocial and behavioral impact of breast cancer risk assessed by testing for common risk variants: protocol of a prospective study |
| Q35092980 | Quality of family history collection with use of a patient facing family history assessment tool |
| Q34778648 | Quantitative assessment of the association between rs2046210 at 6q25.1 and breast cancer risk |
| Q53228289 | RAD50 and NBS1 are not likely to be susceptibility genes in Chinese non-BRCA1/2 hereditary breast cancer. |
| Q57306209 | RAD51C is a susceptibility gene for ovarian cancer |
| Q93130677 | Race/Ethnicity and Accuracy of Self-Reported Female First-Degree Family History of Breast and Other Cancers in the Northern California Breast Cancer Family Registry |
| Q24797050 | Radiation and breast cancer: a review of current evidence |
| Q36649796 | Recalibration of the Gail model for predicting invasive breast cancer risk in Spanish women: a population-based cohort study |
| Q37524981 | Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policies |
| Q37101570 | Recurrent HOXB13 mutations in the Dutch population do not associate with increased breast cancer risk |
| Q92710828 | Recurrent moderate-risk mutations in Finnish breast and ovarian cancer patients |
| Q64101959 | Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study |
| Q37093769 | Relationship between family history of breast cancer and clinicopathological features in Moroccan patients |
| Q35456134 | Replication of breast cancer GWAS susceptibility loci in the Women's Health Initiative African American SHARe Study |
| Q44732408 | Reproductive factors and breast cancer risk in relation to hormone receptor and menopausal status in Japanese women |
| Q30633035 | Retrospective analysis of clinicopathological characteristics and family history data of early-onset breast cancer: a single-institutional study of Hungarian patients |
| Q37230550 | Retrospective analysis of molecular scores for the prediction of distant recurrence according to baseline risk factors. |
| Q40097158 | Risk Factors for Breast Cancer in Gaza Strip, Palestine: a Case-Control Study. |
| Q24628928 | Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis |
| Q35990377 | Risk factors for breast cancer in China: similarities and differences with western populations |
| Q24801118 | Risk factors for breast cancer in Iran: a case-control study. |
| Q39699137 | Risk factors for breast cancer in Pakistani women aged less than 45 years |
| Q52588842 | Risk factors for breast cancer in a cohort of mammographic screening program: a nested case-control study within the FRiCaM study. |
| Q37163224 | Risk factors for pregnancy-associated breast cancer: a report from the Nigerian Breast Cancer Study |
| Q30415050 | Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study |
| Q45209235 | Risk of breast cancer in families of multiple affected women and men. |
| Q34575924 | Risk of cancer development in relation to oral contraception |
| Q91842073 | Risk of primary brain tumour after breast cancer |
| Q36430753 | Risk prediction models for familial breast cancer |
| Q35136955 | Risk prediction of complex diseases from family history and known susceptibility loci, with applications for cancer screening |
| Q38242066 | Risk-benefit assessment of the combined oral contraceptive pill in women with a family history of female cancer |
| Q47317433 | Routine TP53 testing for breast cancer under age 30: ready for prime time? |
| Q97883645 | SNPs in lncRNA Regions and Breast Cancer Risk |
| Q40114778 | Serum Vitamin D and Risk of Breast Cancer within Five Years |
| Q41387543 | Six low-penetrance SNPs for the estimation of breast cancer heritability: A family-based study in Caucasian Italian patients |
| Q89896934 | Sociodemographic and Reproductive Risk Factors for Breast Cancer: A Case-Control Study in the Setif Province, Northern Algeria |
| Q91789687 | Synergistic Effect Between Full-Term Pregnancy/Breastfeeding And Familial Susceptibility On Breast Cancer Risk |
| Q38793447 | Systemic Levels of Estrogens and PGE2 Synthesis in Relation to Postmenopausal Breast Cancer Risk. |
| Q46770883 | TNBC vs. Non-TNBC: A Five-Year Retrospective Review of Differences in Mean Age, Family History, Smoking History and Stage at Diagnosis at an Inner City University Program |
| Q37444608 | Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes |
| Q36946542 | Tamoxifen pharmacogenomics: the role of CYP2D6 as a predictor of drug response |
| Q36695832 | The BOADICEA model of genetic susceptibility to breast and ovarian cancer |
| Q36615665 | The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions |
| Q38874839 | The PARP inhibitor AZD2281 (Olaparib) induces autophagy/mitophagy in BRCA1 and BRCA2 mutant breast cancer cells. |
| Q47553137 | The Sister Study Cohort: Baseline Methods and Participant Characteristics |
| Q33721594 | The Swedish family-cancer database: update, application to colorectal cancer and clinical relevance |
| Q38238014 | The additional cancer yield of clinical breast examination in screening of women at hereditary increased risk of breast cancer: a systematic review |
| Q45105512 | The association between having a first-degree family history of cancer and smoking status |
| Q51326447 | The association between single-nucleotide polymorphisms of ORAI1 gene and breast cancer in a Taiwanese population. |
| Q57131263 | The benefits and harms of breast cancer screening: an independent review |
| Q47439185 | The effect of disease penetrance, family size, and age of onset on family history with application to setting eligibility criteria for genetic testing |
| Q35959353 | The genetic epidemiology of breast cancer genes |
| Q36925187 | The genetics of breast cancer: risk factors for disease |
| Q27013910 | The genetics of cancer risk |
| Q33950555 | The impact of family history of breast cancer on knowledge, attitudes, and early detection practices of Mexican women along the Mexico-US border |
| Q39468964 | The impact of having a sister diagnosed with breast cancer on cancer-related distress and breast cancer risk perception |
| Q37349331 | The impact of in situ breast cancer and family history on risk of subsequent breast cancer events and mortality - a population-based study from Sweden |
| Q89973371 | The impact of patient characteristics and lifestyle factors on the risk of an ipsilateral event after a primary DCIS: A systematic review |
| Q37705926 | The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation |
| Q54269445 | The incidence of PALB2 c.3113G>A in women with a strong family history of breast and ovarian cancer attending familial cancer centres in Australia. |
| Q35476902 | The potential value of sibling controls compared with population controls for association studies of lifestyle-related risk factors: an example from the Breast Cancer Family Registry |
| Q28728296 | The prevalence and correlates of breast cancer among women in Eastern China |
| Q43554932 | The relationship between knowledge of family history and cancer characteristics at diagnosis in women newly-diagnosed with invasive breast cancer |
| Q35124145 | The relationship between seven common polymorphisms from five DNA repair genes and the risk for breast cancer in northern Chinese women |
| Q50044283 | The surprising implications of familial association in disease risk. |
| Q38924493 | The turn of the gradient? Educational differences in breast cancer mortality in 18 European populations during the 2000s |
| Q37172721 | Towards personalized screening: Cumulative risk of breast cancer screening outcomes in women with and without a first-degree relative with a history of breast cancer |
| Q38094973 | Trends in breast cancer incidence and mortality in the United States: implications for prevention |
| Q60175954 | Trends in breast cancer mortality by stage at diagnosis among young women in the United States |
| Q36924465 | Tumour morphology of early-onset breast cancers predicts breast cancer risk for first-degree relatives: the Australian Breast Cancer Family Registry |
| Q35747645 | Tumour spectrum in non-BRCA hereditary breast cancer families in Sweden |
| Q33820594 | Two decades after BRCA: setting paradigms in personalized cancer care and prevention |
| Q36077410 | Understanding breast cancer risk -- where do we stand in 2005? |
| Q34613848 | Urban-rural differences in a population-based breast cancer screening program in Croatia |
| Q38371909 | Use of BRCA Mutation Test in the U.S., 2004-2014. |
| Q44968281 | Use of a patient-entered family health history tool with decision support in primary care: impact of identification of increased risk patients on genetic counseling attendance |
| Q92043569 | Use of detailed family history data to improve risk prediction,with application to breast cancer screening |
| Q31032088 | Use of exogenous hormones and the risk of breast cancer: results from self-reported survey data with validity assessment |
| Q83093542 | Using genetic analysis to individualize preventive measures for breast and ovarian cancers |
| Q36143882 | Using risk-based sampling to enrich cohorts for endpoints, genes, and exposures |
| Q35673555 | Validation of My Family Health Portrait for six common heritable conditions |
| Q36486956 | Why do people postpone parenthood? Reasons and social policy incentives |
| Q38036404 | Women with inoperable or locally advanced breast cancer -- what characterizes them? A retrospective review of 157 cases |
| Q36082470 | Worry is good for breast cancer screening: a study of female relatives from the ontario site of the breast cancer family registry |
| Q23920041 | XRCC1 polymorphisms and breast cancer risk from the New York Site of the Breast Cancer Family Registry: A family-based case-control study |
| Q51122206 | [How to follow-up women with dense breasts by imaging?] |
Search more.